NCT00580502View on ClinicalTrials.gov

Safety and Efficacy of Adjustable Gastric Band Operations for Patients With Body Mass Index (BMI) Between 30-40 kg/m2

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Obesity
Interventions
DEVICE

LAP-BAND® Adjustable Gastric Band (LAGB®)

Bariatric surgery for patient whose BMI is between 30 and 40 kg/m\^2

Sponsors

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

NYU Langone Health

OTHER

NCT00580502 - Safety and Efficacy of Adjustable Gastric Band Operations for Patients With Body Mass Index (BMI) Between 30-40 kg/m2 | Biotech Hunter | Biotech Hunter